1DLH
CRYSTAL STRUCTURE OF THE HUMAN CLASS II MHC PROTEIN HLA-DR1 COMPLEXED WITH AN INFLUENZA VIRUS PEPTIDE
Experimental procedure
| Spacegroup name | P 43 21 2 |
| Unit cell lengths | 94.600, 94.600, 247.500 |
| Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
| Resolution | 7.000 - 2.800 |
| R-factor | 0.205 |
| Rwork | 0.205 |
| R-free | 0.30400 |
| RMSD bond length | 0.018 |
| RMSD bond angle | 2.130 |
| Phasing software | X-PLOR |
| Refinement software | X-PLOR |
Data quality characteristics
| Overall | Outer shell | |
| Low resolution limit [Å] | 20.000 * | |
| High resolution limit [Å] | 2.750 * | 2.750 * |
| Rmerge | 0.067 * | 0.231 * |
| Total number of observations | 88058 * | |
| Number of reflections | 29857 * | |
| Completeness [%] | 94.5 * | 89.8 * |
Crystallization Conditions
| crystal ID | method | pH | temperature | details |
| 1 | Vapor diffusion, hanging drop * | referred to 'Stern, L.J.', (1992) Cell, 68, 465-477 * |
Crystallization Reagents in Literatures
| ID | crystal ID | solution | reagent name | concentration (unit) | details |
| 1 | 1 | reservoir | PEG8000 | 14-17 (%) | |
| 2 | 1 | reservoir | glycine | 100 (mM) |






